AVTX
Avalo Therapeutics Inc
14.60$
-2.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -125.0% | – | – | – | – | – | – | – | |
| – | -18.8% | +14.2% | +1,484.3% | +970.6% | -14.7% | -52.5% | -10.1% | -90.0% | -4.8% | +7.0% | +103.6% | |
| – | -63.7% | +329.4% | -31.7% | +110.1% | +4.2% | +168.0% | +20.4% | -7.6% | -54.0% | +68.3% | +132.8% | |
| – | – | – | – | +5,043.2% | -109.5% | – | -67.9% | – | – | – | – | |
| – | – | -90.6% | -636.0% | – | -123.2% | – | – | +68.0% | -293.7% | – | – | |
| – | +2.5% | +74.6% | -33.1% | +2,319.8% | -53.6% | -76.0% | +79.4% | -15.9% | +66.3% | -100.0% | – | |
| – | +2.5% | +74.6% | +54,116.3% | – | -151.2% | – | -101.0% | -15.9% | +40.0% | – | -23,055.1% | |
| – | – | – | – | – | – | – | – | -55.0% | – | – | – | |
| – | – | – | – | – | – | +176.4% | – | -80.1% | -8.2% | +1.5% | -66.2% | |
| – | – | – | – | -89.2% | +0.0% | – | +0.0% | -145.0% | +43.5% | -100.0% | – | |
| – | -17.8% | -107.3% | – | +178.4% | +20.7% | +256.6% | +138.4% | -113.8% | – | +602.2% | -91.7% | |
| – | +13.2% | -270.2% | – | – | -186.2% | – | +132.5% | -216.2% | – | – | -193.3% | |
| – | – | – | – | -129.5% | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.